Yüklüyor......
Efficacy of Gemfibrozil as an Adjunct to Sertraline in Major Depressive Disorder, A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial
Objective: Major depressive disorder (MDD) is predicted to be one of the biggest disease burden in the future. The antidepressant activity of gemfibrozil has been recently considered. In this study, we assessed the effectiveness of gemfibrozil as a sertraline adjunct in treating patients with MDD. M...
Kaydedildi:
| Yayımlandı: | Iran J Psychiatry |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Psychiatry & Psychology Research Center, Tehran University of Medical Sciences
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8140300/ https://ncbi.nlm.nih.gov/pubmed/34054983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/ijps.v16i1.5379 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|